BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32020550)

  • 21. Growth hormone receptor messenger ribonucleic acid expression in leiomyoma and surrounding myometrium.
    Sharara FI; Nieman LK
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):814-9. PubMed ID: 7573249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative expression of thioredoxin-1 in uterine leiomyomas and myometrium.
    Hou P; Zhao L; Li Y; Luo F; Wang S; Song J; Bai J
    Mol Hum Reprod; 2014 Feb; 20(2):148-54. PubMed ID: 24130091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant expression of Cyr61, a member of the CCN (CTGF/Cyr61/Cef10/NOVH) family, and dysregulation by 17 beta-estradiol and basic fibroblast growth factor in human uterine leiomyomas.
    Sampath D; Zhu Y; Winneker RC; Zhang Z
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1707-15. PubMed ID: 11297607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of G-protein-coupled estrogen receptor-30 in human myometrial and uterine leiomyoma smooth muscle.
    Tian R; Wang Z; Shi Z; Li D; Wang Y; Zhu Y; Lin W; Gui Y; Zheng XL
    Fertil Steril; 2013 Jan; 99(1):256-263.e3. PubMed ID: 23043685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of tumor necrosis factor-α on matrix metalloproteinase-2 expression in human myometrial and uterine leiomyoma smooth muscle cells.
    Wang Y; Feng G; Wang J; Zhou Y; Liu Y; Shi Y; Zhu Y; Lin W; Xu Y; Li Z
    Hum Reprod; 2015 Jan; 30(1):61-70. PubMed ID: 25398968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible involvement of inflammatory/reparative processes in the development of uterine fibroids.
    Protic O; Toti P; Islam MS; Occhini R; Giannubilo SR; Catherino WH; Cinti S; Petraglia F; Ciavattini A; Castellucci M; Hinz B; Ciarmela P
    Cell Tissue Res; 2016 May; 364(2):415-27. PubMed ID: 26613601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lnc-AL445665.1-4 may be involved in the development of multiple uterine leiomyoma through interacting with miR-146b-5p.
    Yang E; Xue L; Li Z; Yi T
    BMC Cancer; 2019 Jul; 19(1):709. PubMed ID: 31319799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional analysis of steroid hormone receptors in smooth muscle uterine leiomyoma tumors of postmenopausal patients.
    Strissel PL; Swiatek J; Oppelt P; Renner SP; Beckmann MW; Strick R
    J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):42-7. PubMed ID: 17646097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
    Commandeur AE; Styer AK; Teixeira JM
    Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development.
    Yang Q; Mas A; Diamond MP; Al-Hendy A
    Reprod Sci; 2016 Feb; 23(2):163-75. PubMed ID: 25922306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative overexpression of the parathyroid hormone-related protein gene in human leiomyomas.
    Weir EC; Goad DL; Daifotis AG; Burtis WJ; Dreyer BE; Nowak RA
    J Clin Endocrinol Metab; 1994 Mar; 78(3):784-9. PubMed ID: 8126157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of matrix metalloproteinase-2 and -9 and contents of their tissue inhibitors in uterine leiomyoma and corresponding myometrium.
    Bogusiewicz M; Stryjecka-Zimmer M; Postawski K; Jakimiuk AJ; Rechberger T
    Gynecol Endocrinol; 2007 Sep; 23(9):541-6. PubMed ID: 17943549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uterine-specific loss of Tsc2 leads to myometrial tumors in both the uterus and lungs.
    Prizant H; Sen A; Light A; Cho SN; DeMayo FJ; Lydon JP; Hammes SR
    Mol Endocrinol; 2013 Sep; 27(9):1403-14. PubMed ID: 23820898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical localization of selected pro-inflammatory factors in uterine myomas and myometrium in women of various ages.
    Plewka A; Madej P; Plewka D; Kowalczyk A; Miskiewicz A; Wittek P; Leks T; Bilski R
    Folia Histochem Cytobiol; 2013; 51(1):73-83. PubMed ID: 23690221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RU486 suppresses prolactin production in explant cultures of leiomyoma and myometrium.
    Stewart EA; Austin DJ; Jain P; Penglase MD; Nowak RA
    Fertil Steril; 1996 Jun; 65(6):1119-24. PubMed ID: 8641483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased expression of early growth response-1 and its role in uterine leiomyoma growth.
    Shozu M; Murakami K; Segawa T; Kasai T; Ishikawa H; Shinohara K; Okada M; Inoue M
    Cancer Res; 2004 Jul; 64(13):4677-84. PubMed ID: 15231681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum sestrin 2 levels in patients with uterine leiomyomas.
    Kabakci M; Topbas Selcuki NF; Aydin Z; Bagci K; Kaya C; Yalcin Bahat P
    J Obstet Gynaecol; 2022 Nov; 42(8):3616-3620. PubMed ID: 36346966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogenic effects of organochlorine pesticides on uterine leiomyoma cells in vitro.
    Hodges LC; Bergerson JS; Hunter DS; Walker CL
    Toxicol Sci; 2000 Apr; 54(2):355-64. PubMed ID: 10774817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian steroid hormones modulate the expression of progesterone receptors and histone acetylation patterns in uterine leiomyoma cells.
    Sant'Anna GDS; Brum IS; Branchini G; Pizzolato LS; Capp E; Corleta HVE
    Gynecol Endocrinol; 2017 Aug; 33(8):629-633. PubMed ID: 28300476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and Cellular Insights into the Development of Uterine Fibroids.
    Machado-Lopez A; Simón C; Mas A
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.